Within the post-ischemia setting, NGAL acts to enhance MMP-9 activation by forming the stable NGAL/MMP-9 complex which, in turn, can amplify and prolong ECM degradation during infarct remodelling [57]. This evidence concerns the gene LCN2 and ischemia.